Seer (SEER)
(Delayed Data from NSDQ)
$1.72 USD
-0.04 (-2.27%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.73 +0.01 (0.58%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SEER 1.72 -0.04(-2.27%)
Will SEER be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SEER based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SEER
Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates
MannKind (MNKD) Q2 Earnings and Revenues Surpass Estimates
SEER: What are Zacks experts saying now?
Zacks Private Portfolio Services
Seer, Inc. (SEER) Reports Q1 Loss, Misses Revenue Estimates
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates
Other News for SEER
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Seer, Inc. Appoints Dr. Nicolas Roelofs to Board of Directors
Seer Appoints Nicolas Roelofs to its Board of Directors
Seer price target lowered by $4 at Morgan Stanley, here's why
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference